To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
65 Current news of Medizinische Uni Wien
rss![]() |
You can refine your search further. Select from the filter options on the left to narrow down your results. |
Better understanding of responses to SARS-CoV-2
29-Sep-2022
Although SARS-CoV-2 infections mainly attack the lungs, in many cases they can also damage other organs, such as the colon: around 60% of patients experienced digestive tract impacts. Researchers at MedUni Vienna have analysed the manifestations of Covid-19 in the lungs and colon and pinpointed ...
Study demonstrates for the first time that ticks weaken skin's immune response
29-Sep-2022
Hitherto, scientists have not fully understood why ticks are such dangerous disease vectors. A research team led by Johanna Strobl and Georg Stary from MedUni Vienna's Department of Dermatology shows that tick saliva inhibits the skin's defence function, thereby increasing the risk of diseases ...
Study shows how neurons compensate for energy supply failures
31-Aug-2022
Researchers at MedUni Vienna have discovered that neurons have an emergency back-up system to enable them to remain functional even when their energy supply is disrupted. As in many areas of technology, an emergency back-up serves to compensate for any energy supply failures experienced by ...
This affects around 15% of the population
16-May-2022
Distinct genetic variants significantly influence an individual's immune response to the SARS-CoV-2 virus and may influence the COVID-19 disease severity. A research group led by MedUni Vienna was able to demonstrate that distinct genetic variants of the CD16a antibody receptor are associated ...
Vaccine developed at MedUni Vienna delivers promising data
07-Apr-2022
The preclinical data for a vaccine developed at MedUni Vienna to protect against SARS-CoV-2 indicates that it is effective against all SARS-CoV-2 variants known to date, including omicron - even in those who have not yet built up any immunity as a result of vaccination (non-responders). The data ...
Researchers discover biomarkers that indicate early brain injury in extreme premature infants
08-Sep-2021
Extremely premature infants are at a high risk for brain damage. Researchers at the University of Vienna and the Medical University of Vienna have now found possible targets for the early treatment of such damage outside the brain: Bacteria in the gut of premature infants may play a key role. The ...
This docking site does not change significantly with mutations of the virus
03-Sep-2021
Around 20% of those who have recovered from Covid-19 fail to develop immune protection against SARS-CoV-2, according to a MedUni Vienna research team led by allergologist and immunologist Rudolf Valenta from the Center for Pathophysiology, Infectiology and Immunology. Their study found that the ...
T cells use their antigen receptors like sticky fingers - a research team was able to observe them doing so
06-May-2021
T-cells play a central role in our immune system: by means of their so-called T-cell receptors (TCR) they make out dangerous invaders or cancer cells in the body and then trigger an immune reaction. On a molecular level, this recognition process is still not sufficiently understood. Intriguing ...
Study provides new information for a better understanding of the disease – and potential biomarkers for vaccine development
04-Nov-2020
In a study recently published in the top journal "Allergy", a team of MedUni Vienna scientists led by immunologist Winfried F. Pickl and allergologist Rudolf Valenta (both from the Center for Pathophysiology, Infectiology and Immunology) showed that there are seven "forms of disease" in COVID-19 ...
Peptide is able to inhibit a particular enzyme that is responsible for the breakdown of messenger molecules in the body
03-Nov-2020
In a recent study, a research group led by Christian Gruber at MedUni Vienna's Institute of Pharmacology isolated a peptide (small protein molecule) from beetroot. The peptide is able to inhibit a particular enzyme that is responsible for the breakdown of messenger molecules in the body. Due to ...